CRISM Therapeutics Company Description

CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs.

Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues.

The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024.

CRISM Therapeutics Corporation was founded in 2016 and is based in Road Town, the British Virgin Islands.

CRISM Therapeutics Corporation

Country	British Virgin Islands
Founded	2016
Industry	Biotechnology
Sector	Healthcare
Employees	4
CEO	Andrew Webb

Contact Details

Address: Kingston Chambers Road Town British Virgin Islands
Website	crismtherapeutics.com

Stock Details

Ticker Symbol	CRTX
Exchange	London Stock Exchange AIM
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	VGG042401262
SIC Code	1000

Key Executives

Name	Position
Andrew Webb	Chief Executive Officer
Ae Swanson	Chief Operating Officer